Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone in Acute Hemorrhagic Stroke
NCT04143880Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Feb 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in hemorrhagic stroke comparing Progesterone Group with Placebo Group (2 arms). Primary endpoint: Modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
progesterone
03
Conditions
hemorrhagic stroke
Beyond the preview
Go deeper on NCT04143880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143880.